These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14599807)

  • 1. The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors.
    Bernt KM; Ni S; Gaggar A; Li ZY; Shayakhmetov DM; Lieber A
    Mol Ther; 2003 Nov; 8(5):746-55. PubMed ID: 14599807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.
    Sova P; Ren XW; Ni S; Bernt KM; Mi J; Kiviat N; Lieber A
    Mol Ther; 2004 Apr; 9(4):496-509. PubMed ID: 15093180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector.
    Huang XW; Lieber A; Tang ZY; Lawrence TS; Moyer MP; Zhang M
    Cancer Gene Ther; 2004 Jun; 11(6):450-6. PubMed ID: 15073612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
    Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
    Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.
    Shayakhmetov DM; Li ZY; Ni S; Lieber A
    Cancer Res; 2002 Feb; 62(4):1063-8. PubMed ID: 11861383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
    Ranki T; Kanerva A; Ristimäki A; Hakkarainen T; Särkioja M; Kangasniemi L; Raki M; Laakkonen P; Goodison S; Hemminki A
    Gene Ther; 2007 Jan; 14(1):58-67. PubMed ID: 16900223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
    Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
    Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
    Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.
    Ni S; Bernt K; Gaggar A; Li ZY; Kiem HP; Lieber A
    Hum Gene Ther; 2005 Jun; 16(6):664-77. PubMed ID: 15960598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.
    Ni S; Gaggar A; Di Paolo N; Li ZY; Liu Y; Strauss R; Sova P; Morihara J; Feng Q; Kiviat N; Touré P; Sow PS; Lieber A
    Cancer Gene Ther; 2006 Dec; 13(12):1072-81. PubMed ID: 16874361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.
    Olmsted-Davis EA; Gugala Z; Gannon FH; Yotnda P; McAlhany RE; Lindsey RW; Davis AR
    Hum Gene Ther; 2002 Jul; 13(11):1337-47. PubMed ID: 12162816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids.
    Yotnda P; Davis AR; Hicks MJ; Templeton NS; Brenner MK
    Mol Ther; 2004 Apr; 9(4):489-95. PubMed ID: 15093179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
    Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
    Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
    Sakurai F; Mizuguchi H; Hayakawa T
    Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D; Meyer B; Wildner O
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.
    Doronin K; Shashkova EV; May SM; Hofherr SE; Barry MA
    Hum Gene Ther; 2009 Sep; 20(9):975-88. PubMed ID: 19469693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.